The Structural Hybrids of Acetylcholinesterase Inhibitors in the Treatment of Alzheimer’s Disease: A Review. Alzheimer’s Disease (AD) is characterized by the loss of memory and learning ability in elderly patients affecting large population worldwide. The enzyme Acetylcholinesterase (AChE), (E.C.3.1.1.7) plays a major role in the hydrolysis of the released neurotransmitter acetylcholine.
No takes yet. Share an insight, caveat, or question.
Anil K. Saxena (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: